PATENT CLAIM ANALYSIS

Application Number: 15759305
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
There has been a demand for a novel antisense nucleic acid or the like capable of inhibiting myostatin at the mRNA level. The present invention provides a specific antisense oligomer which allows exon 2 skipping in the myostatin gene or induces degradation of mRNA of the myostatin gene.

Claim (Index 4):
The antisense oligomer or pharmaceutically acceptable salt or hydrate thereof according to  claim 2 , wherein the antisense oligomer (c) consists of any one nucleotide sequence selected from the group consisting of SEQ ID NO: 103 (NMS-48), SEQ ID NO: 116 (NMS-89), SEQ ID NO: 117 (NMS-90), SEQ ID NO: 120 (NMS-93), SEQ ID NO: 128 (NMS-101), SEQ ID NO: 131 (NMS-104), SEQ ID NO: 136 (NMS-113), SEQ ID NO: 137 (NMS-117), SEQ ID NO: 140 (NMS-123), SEQ ID NO: 145 (NMS-136), SEQ ID NO: 146 (NMS-139), SEQ ID NO: 147 (NMS-140), SEQ ID NO: 148 (NMS-141), SEQ ID NO: 149 (NMS-142), SEQ ID NO: 152 (NMS-145), SEQ ID NO: 155 (NMS-148), SEQ ID NO: 156 (NMS-149), SEQ ID NO: 157 (NMS-150), SEQ ID NO: 159 (NMS-152), SEQ ID NO: 162 (NMS-156), SEQ ID NO: 163 (NMS-157), SEQ ID NO: 165 (NMS-162), SEQ ID NO: 166 (NMS-163), SEQ ID NO: 167 (NMS-164), SEQ ID NO: 168 (NMS-166), SEQ ID NO: 169 (NMS-167), SEQ ID NO: 170 (NMS-168), SEQ ID NO: 171 (NMS-169), SEQ ID NO: 176 (NMS-174), SEQ ID NO: 177 (NMS-175), SEQ ID NO: 178 (NMS-176), SEQ ID NO: 179 (NMS-177), SEQ ID NO: 180 (NMS-178), SEQ ID NO: 183 (NMS-181), SEQ ID NO: 187 (NMS-185), SEQ ID NO: 189 (NMS-188), SEQ ID NO: 190 (NMS-189), SEQ ID NO: 191 (NMS-190), SEQ ID NO: 192 (NMS-191), SEQ ID NO: 193 (NMS-192), SEQ ID NO: 196 (NMS-195), SEQ ID NO: 199 (NMS-198), SEQ ID NO: 200 (NMS-199), SEQ ID NO: 201 (NMS-200), SEQ ID NO: 203 (NMS-202), SEQ ID NO: 204 (NMS-203), SEQ ID NO: 206 (NMS-206), SEQ ID NO: 208 (NMS-208), SEQ ID NO: 212 (NMS-212), SEQ ID NO: 213 (NMS-213), SEQ ID NO: 214 (NMS-214), SEQ ID NO: 215 (NMS-215), SEQ ID NO: 217 (NMS-217), SEQ ID NO: 225 (NMS-225), SEQ ID NO: 226 (NMS-228), SEQ ID NO: 228 (NMS-230), SEQ ID NO: 229 (NMS-231), SEQ ID NO: 231 (NMS-233), SEQ ID NO: 232 (NMS-234), SEQ ID NO: 233 (NMS-235), SEQ ID NO: 236 (NMS-240), SEQ ID NO: 237 (NMS-241), SEQ ID NO: 240 (NMS-244), SEQ ID NO: 243 (NMS-247), SEQ ID NO: 244 (NMS-248), SEQ ID NO: 245 (NMS-249), SEQ ID NO: 246 (NMS-250), SEQ ID NO: 247 (NMS-251), SEQ ID NO: 248 (NMS-252), SEQ ID NO: 252 (NMS-256), SEQ ID NO: 261 (NMS-272), SEQ ID NO: 273 (NMS-284), SEQ ID NO: 274 (NMS-285), SEQ ID NO: 275 (NMS-286) and SEQ ID NO: 277 (NMS-297).

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.38889
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15759267', '15314535', '14368307', '15122435', '15339069']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8504810982939018
- 35 USC 102 Novelty (BERT): 0.5623619347380099
- Combined Prediction Score: 0.8216691819383126
- Mean Citation Score: 427.308318
- Max Citation Score: 475.8151
- Similarity Product: 348.70660524324774

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test